Precision Cardiovascular Medicine

AI-Powered

Harnessing the Power of AI and Precision Epigenetics to

Quantify

risk more precisely

Diagnose

disease earlier

Personalize

care management

Monitor

effectiveness of treatment

Optimize

health outcomes and reduce costs

Accelerate

discovery of novel therapeutics

Innovation Across the Cardiovascular Care Continuum

To meaningfully alter the global trajectory of cardiovascular disease, a paradigm shift is necessary.
Cardio Diagnostics is at the forefront of this change.

Pioneering Precision Cardiovascular Medicine

We pioneered the world's first AI-driven Multi-Omics^TM engine for Precision Cardiovascular Medicine, enabling the rapid prototyping and launch of groundbreaking clinical and data solutions.

Data

Genome-wide genetic

Genome-wide epigenetic

Clinical

Artificial Intelligence

Data mining

Actionable predictive models

Laboratory translation

Wet Lab

Digital PCR

Precision measurements

Scalable techniques

Solutions

Tailored to each stakeholder

Actionable insights

What Makes Our AI-Driven Multi-Omics^TM Engine Powerful

Domain expertise

Our team includes pioneers in the fields of AI and epigenetics, world-class scientists, clinicians, and technologists. Our deep understanding of cardiovascular medicine, molecular biology, and data science drives our innovative approach, enabling the development of solutions that include robust assays and advanced algorithms tailored to meet real-world needs.

Precision

Our clinical solutions use state-of-the-art assays, meticulously developed to ensure high reproducibility. These assays are integral to our solutions, enabling precise measurement and analysis of both epigenetic and genetic markers at scale.

data

Our platform is fueled by high-quality, clinically characterized datasets with billions of molecular biomarker combinations alongside clinical, demographic and cardiovascular health markers. These datasets are continuously refined and expanded, ensuring our technology evolves with the latest scientific discoveries, providing the most advanced foundation for all of our solutions.

Our advanced proprietary AI algorithms efficiently process vast amounts of data to extract meaningful insights including, disease patterns, intervention targets and treatment responses. This significantly enhances diagnostic sensitivity and specificity and allows for patient-specific actionable insights and monitoring.

Scalability

Built for scale, our technology enables seamless integration and analysis of diverse datasets. Our solutions were developed using digital and Taqman PCR based assays combined with machine learning models that can be deployed widely. End-to-end scalability ensures that our solutions can reach as many patients as possible globally.

Reusability

The modular design of our platform allows components to be reused and adapted for different applications, including research and clinical diagnostics. This accelerates the development of new solutions and enhances overall efficiency and cost-effectiveness.

Bridging Clinical Care to
Economic and Strategic Decision-Making

Cardio Diagnostics' innovative and scalable solutions have dual impact by bridging clinical care to economic and strategic decision-making. Our solutions enable precision diagnostics and management to improve patient outcomes while equipping decision makers with actionable insights to optimize healthcare investments while reducing costs.

Clinical Solutions

Only AI and epigenetics-based clinical blood test in the world to predict the three-year risk for a coronary heart disease event, including a heart attack.

Only AI and epigenetics-based clinical blood test in the world for the detection and management of coronary heart disease.

A one-of-a-kind platform that offers new epigenetic and genetic insights to clinicians prescribing the Epi+Gen CHD and PrecisionCHD tests to help improve chronic care management.

Non-Clinical Solutions

A cardiovascular risk intelligence platform customized for healthcare stakeholders including provider organizations, employers, brokers and benefits consultants and government entities, who deploy our clinical solutions to optimize strategic decisions.

Research use only (RUO) platform to support the discovery, development and validation of novel biopharmaceuticals for the assessment, treatment and management of cardiovascular diseases.

Comprehensive
Solutions for Healthcare
Stakeholders

Cardiovascular disease is a problem for all major healthcare stakeholders.
Cardio Diagnostics' solutions provide actionable insights and drive value for these stakeholders.

Learn More